⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1847750 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL720508 | 0.98 | SLC6A1 (0.38) | — | |
| SCHEMBL27529688 | 0.84 | SLC6A1 (0.31) | — | |
| SCHEMBL2707431 | 0.80 | — | — | |
| SCHEMBL27260254 | 0.80 | — | — | |
| SCHEMBL2921164 | 0.80 | — | — | |
| SCHEMBL3364075 | 0.80 | — | — | |
| SCHEMBL6630349 | 0.80 | — | — | |
| SCHEMBL3364084 | 0.77 | — | — | |
| SCHEMBL5620991 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109574955-B | Preparation method of N-hydrogen or N-alkylated thiomorpholine-2-carboxylic acid or carboxylic ester compound | 韶远科技（上海)有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-112811614-A | Circulating water phosphorus-free scale inhibitor and preparation method thereof | 嘉兴沃特泰科环保科技股份有限公司 | 2021-05-18 | — | — | CN | claimed |
| CN-109574955-A | A kind of preparation method of N- hydrogen or N- alkyl sulfur for morpholine -2-carboxylic acid or carboxylic acid ester compound | 韶远科技（上海)有限公司 | 2019-04-05 | — | — | CN | claimed |
| EP-2265585-A1 | AMINE AND ETHER COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2010-12-29 | — | — | EP | claimed |
| WO-2009105509-A1 | AMINE AND ETHER COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-08-27 | — | — | WO | claimed |
| CN-100482800-C | Steroselective preparation of cyclic L-amino acids | RHONE POULENC CHIMIE (FR) | 2009-04-29 | — | — | CN | claimed |
| WO-2009018368-A1 | COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2009-02-05 | — | — | WO | claimed |
| US-7425530-B2 | Stereoselective preparation of cyclic L-amino acids | RHODIA CHIMIE (FR) | 2008-09-16 | — | — | US | claimed |
| US-20050038255-A1 | Industrial scale biosynthesis using cyclodeaminase; yield; such as conversion of ornithine into proline | RHODIA CHIMIE (FR) | 2005-02-17 | — | — | US | claimed |
| CN-1568370-A | treatment of central nervous system disorders with D-amino acid oxidase and D-aspartate oxidase antagonists | GENSET SA (FR) | 2005-01-19 | — | — | CN | claimed |
| CN-1529756-A | Steroselective preparation of cyclic L-amino acids | 罗狄亚化学公司 | 2004-09-15 | — | — | CN | claimed |
| EP-1412515-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | Genset (FR) | 2004-04-28 | — | — | EP | claimed |
| US-20030185754-A1 | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists | GENSET, S.A. (FR) | 2003-10-02 | — | — | US | claimed |
| US-20030166554-A1 | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists | GENSET, S.A. (FR) | 2003-09-04 | — | — | US | claimed |
| WO-2002066672-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | GENSET S.A. (FR) | 2002-08-29 | — | — | WO | claimed |
| US-20250243520-A1 | PRODUCTION METHOD FOR L-CYCLIC AMINO ACIDS | UBE CORPORATION (JP) | 2025-07-31 | — | — | US | disclosed |
| CN-113950534-B | Method for producing L-type cyclic amino acid | 株式会社API | 2025-05-20 | — | — | CN | disclosed |
| WO-2002010750-A2 | BIOSENSORS, REAGENTS AND DIAGNOSTIC APPLICATIONS OF DIRECTED EVOLUTION | MAXYGEN, INC. (US) | 2002-02-07 | — | — | WO | disclosed |
| CN-1302297-A | Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in control of helicobacter bacteria | BYK GULDEN LOMBERG CHEM FAB (DE) | 2001-07-04 | — | — | CN | disclosed |
| WO-1996040781-A1 | CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION | TANABE SEIYAKU CO., LTD. (JP) | 1996-12-19 | — | — | WO | disclosed |